ALIVUS
Alivus Life Sciences Limited
Pharmaceuticals · ₹14,022 Cr market cap
A specialized pharmaceutical manufacturer focused on developing and producing high-value active pharmaceutical ingredients for chronic disease treatments across multiple therapeutic areas. Operating as a subsidiary of Nirma Limited, a diversified conglomerate, the company serves global specialty pharmaceutical companies through contract development and manufacturing services. Its distinctive strength lies in producing non-commoditized APIs where technical expertise, regulatory compliance, and quality standards are paramount.
3
Tracked investors holding
0
Tracked moves
₹1,143
Share price
Top investors holding Alivus Life Sciences Limited
2.51%
Track smart money in Alivus Life Sciences Limited
Get alerted when a top investor buys or sells.
Get started